- Ekso Bionics Holdings Inc (NASDAQ: EKSO) has increased the size of the previously announced public offering to 3.9 million common shares at $10.25 per share, raising around $40 million in gross proceeds from the previous offer of 975,610 shares for $10 million. The offer price is at a 28% discount on the last close price of $13.07 on Monday.
- Underwriters have an option to purchase additional 585,366 shares of common stock.
- The offering is expected to close by February 11.
- H.C. Wainwright & Co. is acting as the sole book-running manager for the offering.
- Ekso Bionics will use the net proceeds for working capital and other general corporate purposes, debt repayment, and acquisitions.
- According to interim fourth-quarter results, revenue is estimated at $2.3 million, down from $3.7 million a year ago. FY2020 is expected to be approximately $8.9 million, lower than $13.9 million in 2019. The cash balance on December 31 stood at $12.9 million.
- Price Action: EKSO slipped 20.8% at 10.35 in premarket trading on the last check Tuesday.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
